The Contrast Between Attending JPM As A Big Pharma Versus A Small Cap

Hunter Smith, CFO, Rhythm Pharmaceuticals, who attended multiple JPMs as an executive with Celgene, discusses in this video segment how a Big Pharma approached attending, planning, and presenting at JPM and how that’s different from attending as the CFO of a small cap biopharmaceutical company. This is a video segment of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, that included Smith; Jim Woody, Ph.D., CEO, 180 Life Sciences; and Terry-Ann Burrell, CFO, Beam Therapeutics (view full video here). The topic for this EVR is the 39th Annual J.P. Morgan Healthcare Conference being 100% virtual in 2021, and how that’s impacting preparations.